Given that NLRP10 deficiency promotes skin inflammation in humans and exacerbates intestinal inflammation in mice, therapeutic strategies aimed at restoring or enhancing NLRP10 function may represent promising anti-inflammatory approaches. This evidence concerns the gene NLRP10 and gastroenteritis.